Insider Buy/Sell Details for the Biotechnology Industry — Last 30 Days
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (157)
Oncotelic Therapeutics, Inc. (OTLC)
Trieu Vuong — Director
Shares
115,000
Price
$0.04
Total Value
$5.17K
Shares Held After
93,884,319
% of Holdings
0.1%
Oncotelic Therapeutics, Inc. (OTLC)
Trieu Vuong — Director
Shares
75,000
Price
$0.04
Total Value
$3.38K
Shares Held After
93,769,319
% of Holdings
0.1%
Faeth Therapeutics, Inc. (FTH)
STEPHENSON BRIAN C — Chief Financial Officer
Shares
425
Price
$25.91
Total Value
$11.01K
Shares Held After
17,413
% of Holdings
2.4%
Faeth Therapeutics, Inc. (FTH)
STEPHENSON BRIAN C — Chief Financial Officer
Shares
1,969
Price
$24.84
Total Value
$48.91K
Shares Held After
16,988
% of Holdings
11.6%
Faeth Therapeutics, Inc. (FTH)
STEPHENSON BRIAN C — Chief Financial Officer
Shares
6,836
Price
$24.12
Total Value
$164.88K
Shares Held After
15,019
% of Holdings
45.5%
BioCardia, Inc. (BCDA)
STERTZER SIMON H — Director
Shares
39,000
Price
$1.00
Total Value
$39.00K
Shares Held After
166,338
% of Holdings
23.4%
Immuneering Corp (IMRX)
Zeskind Benjamin J. — Director
Shares
2,400
Price
$4.56
Total Value
$10.95K
Shares Held After
2,315,252
% of Holdings
0.1%
Oncotelic Therapeutics, Inc. (OTLC)
Trieu Vuong — Director
Shares
65,000
Price
$0.04
Total Value
$2.92K
Shares Held After
93,694,319
% of Holdings
0.1%
Faeth Therapeutics, Inc. (FTH)
Parikh Anand Kiran — Director
Shares
2,806
Price
$19.76
Total Value
$55.45K
Shares Held After
764,234
% of Holdings
0.4%
Faeth Therapeutics, Inc. (FTH)
STEPHENSON BRIAN C — Chief Financial Officer
Shares
356
Price
$23.95
Total Value
$8.53K
Shares Held After
8,183
% of Holdings
4.4%
Faeth Therapeutics, Inc. (FTH)
STEPHENSON BRIAN C — Chief Financial Officer
Shares
3,329
Price
$23.28
Total Value
$77.50K
Shares Held After
7,827
% of Holdings
42.5%
Faeth Therapeutics, Inc. (FTH)
STEPHENSON BRIAN C — Chief Financial Officer
Shares
1,583
Price
$22.40
Total Value
$35.46K
Shares Held After
4,498
% of Holdings
35.2%
Faeth Therapeutics, Inc. (FTH)
STEPHENSON BRIAN C — Chief Financial Officer
Shares
1,118
Price
$20.82
Total Value
$23.28K
Shares Held After
2,915
% of Holdings
38.4%
Faeth Therapeutics, Inc. (FTH)
STEPHENSON BRIAN C — Chief Financial Officer
Shares
1,797
Price
$20.23
Total Value
$36.35K
Shares Held After
1,797
% of Holdings
100.0%
BioCardia, Inc. (BCDA)
STERTZER SIMON H — Director
Shares
70,200
Price
$0.92
Total Value
$64.58K
Shares Held After
127,338
% of Holdings
55.1%
Oncotelic Therapeutics, Inc. (OTLC)
Shah Amit B. — CFO
Shares
20,000
Price
$0.05
Total Value
$1.00K
Shares Held After
378,837
% of Holdings
5.3%
Aditxt, Inc. (ADTX)
HRT FINANCIAL LP — 10% Owner
Shares
7,340,178
Price
$0.01
Total Value
$95.42K
Shares Held After
2,406,438
% of Holdings
305.0%
Cardiff Oncology, Inc. (CRDF)
PACE GARY W — Director
Shares
30,000
Price
$1.22
Total Value
$36.60K
Shares Held After
1,356,376
% of Holdings
2.2%
Cardiff Oncology, Inc. (CRDF)
Mohindru Mani — Director
Shares
24,703
Price
$1.21
Total Value
$29.89K
Shares Held After
24,703
% of Holdings
100.0%
IMMUCELL CORP /DE/ (ICCC)
te Boekhorst Paul Francis Olivier — Director
Shares
8,000
Price
$9.49
Total Value
$75.96K
Shares Held After
17,785
% of Holdings
45.0%
BioCardia, Inc. (BCDA)
Altman Peter — Director
Shares
800
Price
$0.96
Total Value
$768.00
Shares Held After
300,566
% of Holdings
0.3%
Pasithea Therapeutics Corp. (KTTA)
Coastlands Capital LP — 10% Owner
Shares
100,000
Price
$0.53
Total Value
$53.00K
Shares Held After
3,835,035
% of Holdings
2.6%
Nasus Pharma Ltd (NSRX)
Teleman Dan Benjamin — Director
Shares
6,550
Price
$3.10
Total Value
$20.30K
Shares Held After
163,541
% of Holdings
4.0%
BioCardia, Inc. (BCDA)
Altman Peter — Director
Shares
1,500
Price
$0.85
Total Value
$1.27K
Shares Held After
299,766
% of Holdings
0.5%
Oncotelic Therapeutics, Inc. (OTLC)
Trieu Vuong — Director
Shares
239,759
Price
$0.04
Total Value
$10.69K
Shares Held After
93,629,319
% of Holdings
0.3%
PROTHENA CORP PUBLIC LTD CO (PRTA)
SCULLY WILLIAM P — 10% Owner
Shares
20,000
Price
$7.90
Total Value
$157.99K
Shares Held After
756,000
% of Holdings
2.6%
NeuroSense Therapeutics Ltd. (NRSN)
Ben-Noon Alon — Chief Executive Officer
Shares
250,000
Price
$0.80
Total Value
$200.00K
Shares Held After
4,534,233
% of Holdings
5.5%
NeuroSense Therapeutics Ltd. (NRSN)
Eisenberg Or — Chief Financial Officer
Shares
250,000
Price
$0.80
Total Value
$200.00K
Shares Held After
1,504,050
% of Holdings
16.6%
Anixa Biosciences Inc (ANIX)
Titterton Lewis H jr — Director
Shares
2,836
Price
$2.64
Total Value
$7.49K
Shares Held After
972,170
% of Holdings
0.3%
Artiva Biotherapeutics, Inc. (ARTV)
RA CAPITAL MANAGEMENT, L.P. — Director
Shares
124,893
Price
$8.89
Total Value
$1.11M
Shares Held After
16,763,043
% of Holdings
0.7%
Oncotelic Therapeutics, Inc. (OTLC)
Trieu Vuong — Director
Shares
96,000
Price
$0.04
Total Value
$4.32K
Shares Held After
93,389,560
% of Holdings
0.1%
Ocugen, Inc. (OCGN)
Johnson-Greene Treerita Essalima — Chief Financial Officer
Shares
21,000
Price
$1.23
Total Value
$25.83K
Shares Held After
521,000
% of Holdings
4.0%
Keros Therapeutics, Inc. (KROS)
BIENAIME JEAN JACQUES — Director
Shares
1,000
Price
$10.19
Total Value
$10.19K
Shares Held After
17,592
% of Holdings
5.7%
Artiva Biotherapeutics, Inc. (ARTV)
RA CAPITAL MANAGEMENT, L.P. — Director
Shares
15,414
Price
$8.99
Total Value
$138.57K
Shares Held After
16,638,150
% of Holdings
0.1%
Processa Pharmaceuticals, Inc. (PCSA)
Young David — Director
Shares
2,067
Price
$2.22
Total Value
$4.59K
Shares Held After
19,198
% of Holdings
10.8%
Processa Pharmaceuticals, Inc. (PCSA)
Ng George K — Director
Shares
2,465
Price
$2.22
Total Value
$5.47K
Shares Held After
12,435
% of Holdings
19.8%
Processa Pharmaceuticals, Inc. (PCSA)
SKIBSTED RUSSELL — Chief Financial Officer
Shares
2,654
Price
$2.22
Total Value
$5.89K
Shares Held After
13,412
% of Holdings
19.8%
Immuneering Corp (IMRX)
Hall Brett Matthew — CHIEF SCIENTIFIC OFFICER
Shares
6,035
Price
$4.15
Total Value
$25.05K
Shares Held After
382,531
% of Holdings
1.6%
Processa Pharmaceuticals, Inc. (PCSA)
Lin Patrick — Chief Business - Strategy Off
Shares
1,831
Price
$2.22
Total Value
$4.06K
Shares Held After
11,007
% of Holdings
16.6%
Processa Pharmaceuticals, Inc. (PCSA)
Guy Wendy — Chief Administrative Officer
Shares
2,118
Price
$2.22
Total Value
$4.70K
Shares Held After
11,958
% of Holdings
17.7%
Artiva Biotherapeutics, Inc. (ARTV)
RA CAPITAL MANAGEMENT, L.P. — Director
Shares
391,019
Price
$8.57
Total Value
$3.35M
Shares Held After
16,622,736
% of Holdings
2.4%
Aditxt, Inc. (ADTX)
HRT FINANCIAL LP — 10% Owner
Shares
4,252,767
Price
$0.02
Total Value
$68.04K
Shares Held After
2,459,308
% of Holdings
172.9%
Anixa Biosciences Inc (ANIX)
KUMAR AMIT — Director
Shares
21,000
Price
$2.50
Total Value
$52.50K
Shares Held After
630,812
% of Holdings
3.3%
FRACTYL HEALTH, INC. (GUTS)
Royan Ajay — Director
Shares
23,000
Price
$0.85
Total Value
$19.60K
Shares Held After
40,901
% of Holdings
56.2%
60 DEGREES PHARMACEUTICALS, INC. (SXTP)
DOW GEOFFREY S — Director
Shares
7,350
Price
$1.38
Total Value
$10.13K
Shares Held After
24,131
% of Holdings
30.5%
Serina Therapeutics, Inc. (SER)
WILSON KAREN J — Director
Shares
5,000
Price
$1.77
Total Value
$8.85K
Shares Held After
10,100
% of Holdings
49.5%
Tonix Pharmaceuticals Holding Corp. (TNXP)
Taylor Carolyn E. — Director
Shares
1,415
Price
$10.55
Total Value
$14.93K
Shares Held After
1,833
% of Holdings
77.2%
Summit Therapeutics Inc. (SMMT)
Zanganeh Mahkam — Director
Shares
3,810,000
Price
$13.12
Total Value
$49.99M
Shares Held After
573,883,879
% of Holdings
0.7%
Summit Therapeutics Inc. (SMMT)
DUGGAN ROBERT W — Director
Shares
3,810,000
Price
$13.12
Total Value
$49.99M
Shares Held After
573,883,879
% of Holdings
0.7%
Aditxt, Inc. (ADTX)
BANK OF AMERICA CORP /DE/ — 10% Owner
Shares
3
Price
$0.01
Total Value
$0.03
Shares Held After
64
% of Holdings
4.7%
Showing 1–50 of 157 transactions (page 1 of 4)